What to Know in Washington: Biden, Suga Meeting All About China

President Joe Biden’s effort to harness U.S. alliances in Asia to counter China will get a test run during his summit with Japanese Prime Minister Yoshihide Suga today -- his first in-person meeting with a foreign leader since taking office.

HEALTH CARE BRIEFING: Holistic Drug Reform Eyed to Fix Inequity

Lawmakers seeking to lower drug costs should take a comprehensive approach rather than focus solely on manufacturers’ pricing practices—a strategy that’s only created disparities in the marketplace, policy analysts say.

Republicans’ Big Tech Plan Gives Democrats’ Opening for Overhaul

A legislative outline from House Republican staff to overhaul the regulation of technology companies such as Facebook and Google shows room for bipartisan and industry agreement this Congress.

Gender Wage Gap Bill Passes House as Democrats Press for Equity

House lawmakers passed legislation Thursday to close pay gaps for women by tackling loopholes in federal wage equity law, a priority for President Joe Biden’s administration.

Deep Divisions Over Transit Threaten Highway Bill Bipartisanship

Transit is emerging as a key partisan split as lawmakers draft legislation to reauthorize surface transportation programs and respond to President Joe Biden’s $2.25 trillion infrastructure plan.

Food-Aid Politics Take Stage as Vilsack Cancels Trump Program

Partisan tensions between Democrats and Republicans have spilled over into debate over how to help hungry Americans during the coronavirus pandemic, following a recent Agriculture Department decision to end a Trump-era food box program.

What to Know in Washington: Biden Climate Debut Risks Shortfall

John Kerry has been flying around the world trying to get some of the biggest polluters to step up their fight against climate change in time for a White House summit on April 22. If new goals are the measure of success, the meeting is shaping up to be a disappointment.

HEALTH CARE BRIEFING: CDC Advisers Punt on J&J Vaccine Decision

U.S. public health advisers concluded a meeting on Johnson & Johnson’s coronavirus vaccine without a vote, effectively extending a halt on its use as they seek more data on an extremely rare blood clotting side effect.

Fentanyl Ban Complicates Biden’s Plan to Shift Drug Policy (1)

President Joe Biden is facing a crucial test of his promise to reduce overdose deaths in the U.S. through addiction treatment, civil rights and drug policy groups say.

This Is IT: ‘Skinny’ Budget Prioritizes IT Modernization, Cyber

For a skinny budget that’s even slimmer than typical in new administrations, there’s a big focus on information technology and cybersecurity with details and budget figures that indicate there will be more money for both in fiscal 2022....
Load More